Index. Note: Page numbers of article titles are in boldface type.

Transcription

1 Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), causes of, defined, incidence of, management of, bioartificial liver support systems in clinical efficacy of, cause-specific, complications-related, liver transplantation in, non-cause-specific, 960 Acute-on-chronic liver failure (ACLF) described, 964 management of artificial liver support systems in clinical efficacy of, ICU, pathophysiology of, 964 prognosis of initial assessment of, Acute variceal bleeding (AVB), described, management of esophageal stents in, general, 795 hemostatic therapies in, EBL, endoscopic therapy, 796 splanchnic vasoconstrictors, TIPS in, 855 natural history/diagnosis of, refractory TIPS for, AKI. See Acute kidney injury (AKI) Alcoholic hepatitis HVPG measurement in, 785 ALF. See Acute liver failure (ALF) Clin Liver Dis 18 (2014) /14/$ see front matter ª 2014 Elsevier Inc. All rights reserved. liver.theclinics.com

2 980 Index Ascites refractory AVB. See Acute variceal bleeding (AVB) B Balloon-occluded retrograde transvenous obliteration (BRTO) procedure in gastric varices management, 819, outcomes in American institutions, outcomes in Asian institutions, TIPS with outcomes of, Balloon tamponade in gastric varices management, 814 Bile duct stones cholangioscopy for outcomes of, Biliary anastomotic strictures after liver transplantation cholangioscopy for, 921 diagnostic approach to, ERCP for, See also Endoscopic retrograde cholangiopancreatography (ERCP), for biliary anastomotic strictures after liver transplantation recurrence of, 920 risk factors for, 915 treatment of, Biliary malignancies suspected cholangioscopy for outcomes of, Biliary strictures anastomotic. See Biliary anastomotic strictures LDLT and, types of, Bleeding acute variceal, See also Acute variceal bleeding (AVB) gastrointestinal in ACLF patients, refractory gastric varices and portal hypertensive gastropathy and, 857 variceal. See Variceal bleeding BRTO procedure. See Balloon-occluded retrograde transvenous obliteration (BRTO) procedure Budd-Chiari syndrome TIPS for, 859 C Cancer(s). See also Carcinoma(s) liver

3 radioembolization for, TACE for, See also Transarterial chemoembolization (TACE), for liver cancer Carcinoma(s). See also Cancer(s) hepatocellular. See Hepatocellular carcinoma (HCC) Chemoembolization transarterial for liver cancer. See also Transarterial chemoembolization (TACE) Cholangiocarcinoma benign stenosis vs. in PSC patients, described, 891 ERCP for, See also Endoscopic retrograde cholangiopancreatography (ERCP) Cholangioscopy in liver disease, approach to, for bile duct stones outcomes of, for biliary anastomotic strictures after liver transplantation, 921 clinical implications of, 938 complications/management of, 938 current controversies/future considerations in, follow-up care, 938 indications/contraindications to, 928 introduction, outcomes of, postprocedure care, 938 preparation for, for PSC, 907 outcomes of, 937 reporting of, 938 for suspected biliary malignancies outcomes of, technique for, Cholangitis primary sclerosing ERCP for, See also Endoscopic retrograde cholangiopancreatography (ERCP), for PSC; Primary sclerosing cholangitis (PSC) Chronic liver disease (CLD) described, 768 Cirrhosis prognosis of HVPG measurement in, severity of HVPG measurement in, CLD. See Chronic liver disease (CLD) Conventional TACE (ctace) for liver cancer technique/procedure for, Index 981

4 982 Index D Drug-eluting bead TACE for liver cancer technique/procedure for, 882 E EBL. See Endoscopic band ligation (EBL) Endoscopic band ligation (EBL) in AVB management, in gastric varices management, 816 Endoscopic retrograde cholangiopancreatography (ERCP) for biliary anastomotic strictures after liver transplantation, complications of, 921 dilation and plastic stent placement, 917 introduction, limitations of, self-expandable metal stents, for cholangiocarcinoma, complications/management of, current controversies/future considerations in, 896 indications/contraindications to, outcomes of, postoperative care, 895 technique/procedure for, introduction, 891 for PSC, See also Primary sclerosing cholangitis (PSC) complications of, introduction, Endoscopic sphincterotomy for PSC, 902 Endoscopic stent placement for PSC, Endoscopic stricture dilation for PSC, Endoscopic therapies in AVB management, 796 combined in gastric varices management, 818 in gastric varices management, 814 in gastric varices prevention, 820 Endoscopic ultrasound (EUS) guided therapy in gastric varices management, Endovascular procedures in gastric varices management, See also specific methods and Gastric varices, management of, endovascular ERCP. See Endoscopic retrograde cholangiopancreatography (ERCP) Esophageal stents in AVB management, EUS. See Endoscopic ultrasound (EUS)

5 Index 983 G Gastric varices acute management of, 813 anatomy related to, vascular, classification of, 810, hemodynamic features of, introduction, management of, balloon tamponade in, 814 band ligation in, 816 BRTO procedure in, 819, endoscopic therapies in, 814 combined, 818 endovascular, BRTO procedure, outcomes in American institutions, outcomes in Asian institutions, introduction, TIPS only in outcomes of, 846 EUS guided treatment in, medical, obturation in, primary prophylaxis in, radiologic interventions in, 819 risk factors associated with, 813 sclerotherapy in, secondary prophylaxis in, thrombin in, TIPS in, 819 refractory bleeding from terminology related to, Gastroesophageal varices. See also Gastric varices introduction, Gastrointestinal bleeding in ACLF patients, Gastropathy portal hypertensive refractory bleeding from H HCC. See Hepatocellular carcinoma (HCC) Hemodynamic instability in ACLF patients management of,

6 984 Index Hemostatic therapies in AVB management, See also Acute variceal bleeding (AVB), management of, hemostatic therapies in Hepatic venoocclusive disease TIPS for, 859 Hepatic venous pressure gradient (HVPG) measurement, applications of, alcoholic hepatitis, 785 assessment of new therapeutic agents, 788 assessment of response to pharmacologic therapy to decrease portal pressure, cirrhosis prognosis, cirrhosis severity, hepatocellular carcinoma, 786 liver transplantation, portal hypertension classification, 784 portal hypertension diagnosis, viral hepatitis, 785 Hepatitis alcoholic HVPG measurement in, 785 viral HVPG measurement in, 785 Hepatocellular carcinoma (HCC) HVPG measurement in, 786 introduction, Hepatopulmonary syndrome (HPS) TIPS for, Hepatorenal syndrome (HRS) TIPS for, 859 HPS. See Hepatopulmonary syndrome (HPS) HRS. See Hepatorenal syndrome (HRS) HVPG. See Hepatic venous pressure gradient (HVPG) Hydrothorax refractory hepatic TIPS for, 858 Hypertension portal. See Portal hypertension I ICU. See Intensive care unit (ICU) Infection(s) in ACLF patients, 964 Intensive care unit (ICU) liver failure patients in management of, See also Liver failure, ICU management of patients with Interventional radiologic approach in gastric varices prevention, 820

7 Index 985 L LDLT. See Living donor liver transplantation (LDLT) Liver biopsy transjugular, See also Transjugular liver biopsy (TJLB) Liver cancer radioembolization for, TACE for, See also Transarterial chemoembolization (TACE), for liver cancer Liver disease cholangioscopy in, See also Cholangioscopy, in liver disease Liver failure acute. See Acute liver failure (ALF) acute-on-chronic. See Acute-on-chronic liver failure (ACLF) ICU management of patients with, ACL patients, See also Acute liver failure (ALF) ACLF patients, liver support systems in, See also Liver support systems Liver support systems bioartificial in ALF, extracorporeal technical characteristics of, 946 in liver failure, artificial vs. bioartificial systems analysis clinical studies, 953 clinical efficacy of, in ACLF, in ALF, 949 bioartificial liver support systems in ALF, future considerations, ideal requirements for, in improving liver regeneration, 948 in improving portal and systemic hemodynamics, rationale for, in toxins elimination, necessity of, Liver transplantation for ALF, biliary anastomotic strictures after. See also Biliary anastomotic strictures, after liver transplantation ERCP for, See also Biliary anastomotic strictures; Endoscopic retrograde cholangiopancreatography (ERCP), for biliary anastomotic strictures after liver transplantation HVPG measurement and, living donor biliary strictures and, Living donor liver transplantation (LDLT) biliary strictures and,

8 986 Index M Malignancy(ies) biliary suspected cholangioscopy for, Medical therapies in gastric varices prevention, 820 N Neurologic complications in ACLF patients, O Obturation in gastric varices management, P Partial splenic embolization (PSE) in gastric varices prevention, 820 Portal hypertension classification of HVPG measurement in, 784 described, diagnosis of HVPG measurement in, Portal hypertensive gastropathy refractory bleeding from Portal pressure decrease in HVPG measurement in assessment of response to pharmacologic therapy for, introduction, measurement of, HVPG related, Primary sclerosing cholangitis (PSC) cholangioscopy for outcomes of, 937 cholangioscopy in role of, 907 described, diagnosis of, 900 dominant stricture in, management of endoscopic, medical, 901 nonendoscopic, percutaneous, 901 surgical, 902

9 Index 987 endoscopic management of efficacy of, 904 ERCP for, See also Endoscopic retrograde cholangiopancreatography (ERCP), for PSC PSC. See Primary sclerosing cholangitis (PSC) PSE. See Partial splenic embolization (PSE) Pulmonary complications in ACLF patients, 970 R Radioembolization for liver cancer, Radiologic procedures in gastric varices management, 819 Refractory acute variceal bleeding TIPS for, Refractory ascites Refractory bleeding gastric varices and portal hypertensive gastropathy and Refractory hepatic hydrothorax TIPS for, 858 S Sclerotherapy in gastric varices management, Septic shock in ACLF patients management of, Sphincterotomy endoscopic for PSC, 902 Splanchnic vasoconstrictors in AVB management, Stent(s) esophageal in AVB management, Suspected biliary malignancies cholangioscopy for outcomes of, T TACE. See Transarterial chemoembolization (TACE) Thrombin in gastric varices management, TIPS. See Transjugular intrahepatic portosystemic shunts (TIPS) TJLB. See Transjugular liver biopsy (TJLB)

10 988 Index Toxin(s) liver failure related elimination of liver support systems in, Transarterial chemoembolization (TACE) for liver cancer, clinical implications of, complications/management of, 883 ctace technique/procedure for, current controversies/future considerations in, drug-eluting bead type technique/procedure for, 882 follow-up care, indications/contraindications for, 879 introduction, outcomes of, postprocedure care, reporting related to, technique/procedure for, Transjugular intrahepatic portosystemic shunts (TIPS), advanced/alternative techniques for, 864 complications of, conventional technique for, evaluation prior to, follow-up care, 867 future considerations in, 867 in gastric varices management, 819 with BRTO procedure outcomes of, outcomes of, 846 indications for, AVB, 855 refractory, Budd-Chiari syndrome, 859 hepatic venoocclusive disease, 859 HPS, HRS, 859 refractory ascites, 857 refractory bleeding from gastric varices and portal hypertensive gastropathy, 857 refractory hepatic hydrothorax, 858 variceal hemorrhage prevention, introduction, maintenance care, 867 patient selection for, Transjugular liver biopsy (TJLB), complications/management of, 774 current controversies/future considerations in, 776 indications/contraindications to, 768 sample quality and clinical implications in, technique/procedure for,

11 Index 989 Transplantation(s) liver. See Liver transplantation V Variceal bleeding acute refractory TIPS for, TIPS for, 855 prevention of TIPS in, Varices gastric. See Gastric varices Vasoconstrictor(s) splanchnic in AVB management, Venoocclusive disease hepatic TIPS for, 859 Viral hepatitis HVPG measurement in, 785